Vitalbacteria kits have been designed and developed with the University of St Andrews and represent a new opportunity for the rapid and effective diagnosis of TB through molecular bacterial load assay (MBLA). MBLA works by amplifying the 16S ribosomal RNA (rRNA) of M. tuberculosis in a PCR reaction which takes less than four hours to provide a result which is specific to M. tuberculosis and is not compromised by any other organisms which can be found in patient samples.

​

The most popular current method for diagnosis and the assessment of performance of treatments of TB is bacterial culture which is a much slower and more expensive process, so we believe that Vitalbacteria kits represent a leap forward in the fight against TB.